Nuvalent Inc - Ordinary Shares - Class A Stock
Nuvalent Inc - Ordinary Shares - Class A Stock price
Key metrics
| Market capitalization | $6.79b |
| Enterprise Value | $5.63b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 6.05 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-240.51m |
| Free Cash Flow (TTM) Free Cash Flow | $-153.27m |
| Cash position | $1.17b |
Is Nuvalent Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Nuvalent Inc - Ordinary Shares - Class A Stock Analysis
Analyst Opinions
13 Analysts have issued a Nuvalent Inc - Ordinary Shares - Class A forecast:
Analyst Opinions
13 Analysts have issued a Nuvalent Inc - Ordinary Shares - Class A forecast:
Financial data from Nuvalent Inc - Ordinary Shares - Class A
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -241 -241 |
82%
82%
|
EBIT (Operating Income) EBIT | -241 -241 |
82%
82%
|
| Net Profit | -224 -224 |
97%
97%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Nuvalent Inc - Ordinary Shares - Class A directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nuvalent Inc - Ordinary Shares - Class A Stock News
Company Profile
Nuvalent, Inc. operates as a preclinical stage biopharmaceutical company. The company creates precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Its focus its discovery efforts on small molecule inhibitors of kinases, a class of cellular targets that can play a central role in cancer growth and proliferation. The company was founded in January 2017 and is headquartered Cambridge, MA.
| Head office | United States |
| CEO | James Porter |
| Employees | 92 |
| Founded | 2017 |
| Website | www.nuvalent.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
